Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Operating Expenses | 8,758 | 9,891 | 12,402 | 8,755 | 7,038 |
| Operating Income | -8,758 | -9,891 | -12,402 | -8,755 | -7,038 |
| Interest Expense | 0 | 446 | 9 | 8 | 430 |
| Other Income | 3,263 | 2,285 | 1,629 | -34 | 32 |
| Pre-tax Income | -5,495 | -8,052 | -10,782 | -8,797 | -7,435 |
| Net Income Continuous | -5,495 | -8,052 | -10,782 | -8,797 | -7,435 |
| Net Income | $-5,495 | $-8,052 | $-10,782 | $-8,797 | $-7,435 |
| EPS Basic Total Ops | -21,111.11 | -52,642.64 | -115,915.90 | -0.23 | -0.31 |
| EPS Basic Continuous Ops | -21,102.45 | -52,650.28 | -115,845.70 | -0.21 | -0.31 |
| EPS Diluted Total Ops | -21,111.11 | -52,642.64 | -115,915.90 | -0.23 | -0.31 |
| EPS Diluted Continuous Ops | -21,102.45 | -52,650.28 | -115,845.70 | -0.21 | -0.31 |
| EBITDA(a) | $-8,395 | $-9,524 | $-11,977 | $-8,258 | $-6,453 |